| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Platform: GPL11154
|
Mark Dawson
|
||||||
| GSE88746 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [ChIP-seq 1]
|
3 | Mark Dawson | Jul 13, 2017 | ||||
| GSE88747 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [ChIP-seq 2]
|
8 | Mark Dawson | Jul 13, 2017 | ||||
| GSE88748 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 1]
|
6 | Mark Dawson | Jul 13, 2017 | ||||
| GSE88749 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [Click-Seq 2]
|
10 | Mark Dawson | Jul 13, 2017 | ||||
| GSE88750 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq]
|
9 | Mark Dawson | Jul 13, 2017 | ||||
| GSE88751 |
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies
|
36 | Mark Dawson | Jul 13, 2017 | ||||
| GSE81147 |
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946
|
8 | Mark Dawson | Jun 20, 2016 | ||||
| GSE81148 |
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946
|
12 | Mark Dawson | Jun 20, 2016 | ||||
| GSE71776 |
ChIPSeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946
|
16 | Mark Dawson | Jun 12, 2016 | ||||
| GSE71777 |
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946
|
8 | Mark Dawson | Jun 12, 2016 | ||||
| GSE71779 |
ChIPSeq of MV4;11 cell treated with SGC0946 for 8 hours and washout
|
9 | Mark Dawson | Jun 12, 2016 | ||||
| GSE71780 |
Functional interdependency of BRD4 and DOT1L in MLL leukaemia
|
33 | Mark Dawson | Jun 12, 2016 |
